Bovine PTGES (Prostaglandin E synthase) ELISA Kit

Este producto es parte de PTGES - Prostaglandin E synthase
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Bovine PTGES (Prostaglandin E synthase) ELISA Kit
category
ELISA Kits
provider
FineTest
reference
EB0122
tested applications
ELISA

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
ELISA Kits
Reactivity
Bovine
Detection Method
Colorimetric
Assay Data
4 hours
Assay Type
Sandwich ELISA, Double Antibody
Test Range
0.313-20ng/ml
Sensitivity
0.188ng/ml
Size 1
96T
Tested Applications
ELISA
Sample Type
Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
Availability
Shipped within 10-14 working days.
Storage
2-8 °C for 12 months
UniProt ID
Q95L14
Alias
MGST1L1,MPGES1,PGES,PIG12,Microsomal prostaglandin E synthase 1,p53-induced gene 12 protein,PP1294,MGST-IV,MGST1L1,TP53I12;,mPGES-1,MGST1-L1
Background
Elisa kits for PTGES
Status
RUO

Prostaglandin E synthase (PTGES) is an inducible enzyme that catalyzes the conversion of prostaglandin H2 (PGH2) to prostaglandin E2 (PGE2), a bioactive lipid mediator involved in a wide range of physiological and pathological processes, including inflammation, fever, pain perception, and tissue homeostasis. PTGES is typically upregulated in response to pro-inflammatory stimuli such as cytokines (e.g., TNF-α and IL-1β) and oxidative stress, making it a key component of the inflammatory response. It is closely associated with cyclooxygenase-2 (COX-2), as both enzymes are induced during inflammation, and they work in tandem to elevate PGE2 levels. Overexpression of PTGES has been implicated in various diseases, including cancer, rheumatoid arthritis, and cardiovascular disorders, where increased PGE2 production contributes to tumor growth, immune evasion, chronic inflammation, and vascular dysfunction. PTGES is predominantly expressed in the cytoplasm and is regulated by transcriptional and post-translational mechanisms, including phosphorylation. Targeting PTGES has emerged as a potential therapeutic strategy to modulate PGE2 levels while avoiding the side effects associated with COX inhibitors, making it an area of active pharmacological research.

Related Products

EB0122

Bovine PTGES (Prostaglandin E synthase) ELISA Kit

Ver Producto
EH1740

Human PTGES (Prostaglandin E synthase) ELISA Kit

Ver Producto
EM1316

Mouse PTGES (Prostaglandin E Synthase, Microsomal) ELISA Kit

Ver Producto